Roche Must Pay $18 Million to Two Former Accutane Users

Roche Holding AG must pay a total of $18 million in damages to two former users of its Accutane acne drug who blamed the medicine for their bowel disease, a New Jersey jury ruled.
Read article at bloomberg.com